12-62054143-T-C
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_178539.5(TAFA2):c.-2+137116A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.826 in 152,124 control chromosomes in the GnomAD database, including 52,069 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_178539.5 intron
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_178539.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TAFA2 | NM_178539.5 | MANE Select | c.-2+137116A>G | intron | N/A | NP_848634.1 | Q8N3H0-1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TAFA2 | ENST00000416284.8 | TSL:1 MANE Select | c.-2+137116A>G | intron | N/A | ENSP00000393987.3 | Q8N3H0-1 | ||
| TAFA2 | ENST00000549379.5 | TSL:1 | n.-211-30364A>G | intron | N/A | ENSP00000447584.1 | A0A0C4DGI5 | ||
| TAFA2 | ENST00000551619.5 | TSL:2 | c.-129-30364A>G | intron | N/A | ENSP00000447305.1 | Q8N3H0-1 |
Frequencies
GnomAD3 genomes AF: 0.826 AC: 125509AN: 152008Hom.: 52003 Cov.: 31 show subpopulations
GnomAD4 genome AF: 0.826 AC: 125632AN: 152124Hom.: 52069 Cov.: 31 AF XY: 0.826 AC XY: 61453AN XY: 74356 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at